Yano Shigetoshi, Hide Takuichiro, Shinojima Naoki
Department of Neurosurgery, Faculty of Life Sciences Research, Kumamoto University Graduate School, Kumamoto, Japan.
Department of Neurosurgery, Faculty of Life Sciences Research, Kumamoto University Graduate School, Kumamoto, Japan.
World Neurosurg. 2017 Apr;100:288-296. doi: 10.1016/j.wneu.2017.01.005. Epub 2017 Jan 12.
Sparing the hypothalamus after craniopharyngioma treatment is a prerequisite to ensure a good quality of life. In this study, the functional prognosis of craniopharyngioma after endoscopic endonasal skull base surgery (EES) was examined in function of the degree of hypothalamic extension.
Twenty cases of craniopharyngioma treated by EES were categorized according to the Puget classification using preoperative and postoperative magnetic resonance imaging. The degree of resection rates, amelioration of symptoms, and endocrinologic and hypothalamic functions were evaluated during the postoperative follow-up period.
All cases were preoperatively classified into grades 0 (n = 8), 1 (n = 7), and 2 (n = 5). Near total resection was achieved in half of the cases. Moreover, visual improvement was observed in 75% of the cases. The incidence rate of additional endocrinologic dysfunction was not related to the preoperative grade or intraoperative stalk preservation. Postoperative magnetic resonance imaging indicated hypothalamic preservation for all grades. After an average of 60 months follow-up of 11 patients with primary tumors, 4 patients showed tumor regrowth controlled by stereotactic radiation therapy. All patients recorded more than 80% on the Karnofsky Performance Scale and showed no additional obesity at follow-up.
EES provides optimal resection rate and limited complications because of the preservation of the hypothalamus, regardless of the degree of preoperative hypothalamic involvement. Consequently, the rate of obesity occurrence is also decreased. This study indicates that EES protects hypothalamus function and improves tumor removal rate, and that it will become the first choice of surgical procedure for managing craniopharyngiomas.
颅咽管瘤治疗后保留下丘脑是确保良好生活质量的前提条件。在本研究中,根据下丘脑受累程度,对内镜经鼻颅底手术(EES)治疗颅咽管瘤后的功能预后进行了研究。
采用术前和术后磁共振成像,根据普吉特分类法对20例行EES治疗的颅咽管瘤病例进行分类。在术后随访期间评估切除率、症状改善情况以及内分泌和下丘脑功能。
所有病例术前均分为0级(n = 8)、1级(n = 7)和2级(n = 5)。一半的病例实现了近全切除。此外,75%的病例视力得到改善。额外内分泌功能障碍的发生率与术前分级或术中垂体柄保留无关。术后磁共振成像显示所有分级的下丘脑均得以保留。对11例原发性肿瘤患者平均随访60个月后,4例患者的肿瘤复发通过立体定向放射治疗得到控制。所有患者的卡氏功能状态评分均超过80%,且随访时未出现额外的肥胖。
无论术前下丘脑受累程度如何,EES由于保留了下丘脑,提供了最佳的切除率且并发症有限。因此,肥胖发生率也降低了。本研究表明,EES保护下丘脑功能并提高肿瘤切除率,将成为治疗颅咽管瘤的首选手术方法。